SCHEMBL23536217

SCHEMBL23536217

Fc1cncc(Br)c1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL617427 0.81
SCHEMBL27905213 0.81
SCHEMBL15783896 0.74
SCHEMBL15577679 0.70
SCHEMBL31555008 0.70
SCHEMBL31231585 0.70
SCHEMBL25309315 0.70
SCHEMBL792456 0.70
SCHEMBL20657252 0.70
SCHEMBL13725666 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388583-A1 COMPOUNDS AND METHOD FOR PKMYT1 INHIBITION ENGINE BIOSCIENCES PTE LTD (SG) 2025-12-25 US disclosed
EP-4543881-A1 COMPOUNDS AND METHOD FOR PKMYT1 INHIBITION Engine Biosciences Pte. Ltd. (SG) 2025-04-30 EP disclosed
WO-2023249563-A1 COMPOUNDS AND METHOD FOR PKMYT1 INHIBITION ENGINE BIOSCIENCES PTE. LTD. (SG) 2023-12-28 WO disclosed
US-20230104936-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. 2023-04-06 US disclosed
EP-4076423-A1 TRPML MODULATORS Casma Therapeutics, Inc. (US) 2022-10-26 EP disclosed
CN-115087440-A TRPML modulators 卡斯玛治疗公司 2022-09-20 CN disclosed
WO-2021127337-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed